患者健康问卷躯体症状群量表在综合医院的筛检价值

发布时间：2019-07-23 21:29

【摘要】：目的:探讨患者健康问卷躯体症状群量表(PHQ-15)中文版在综合医院门诊的筛检价值。方法:600名综合医院普通门诊患者在规定指导语下完成PHQ-15中文版、广泛性焦虑量表(GAD-7)、抑郁症状群量表(PHQ-9)自评量表,并接受经过培训的精神科专业人员进行汉密顿焦虑量表(HAMA)和汉密顿抑郁量表(HAMD)的评定。随机抽取其中44名患者在完成初次评定后7~14 d内接受PHQ-15重测。以HAMA、HAMD、GAD-7、PHQ-9为效标,分别与PHQ-15进行相关分析。计算躯体症状群检出率,并分析其人口学特征。分析PHQ-15不同分数段与焦虑、抑郁症状群的关系。结果:PHQ-15内部一致性信度系数为0.73,重测信度系数为0.75。PHQ-15得分与HAMA、HAMD、GAD-7、PHQ-9得分均呈正相关(r=0.65、0.68、0.52、0.73,均P0.05)。探索性因素分析得到全身不适、胃肠不适和心胸不适3个公因子。检出躯体症状群者共364人,占总样本量的60.7%。不同性别、年龄、就业情况和就诊科室患者的躯体症状群检出率差异均有统计学意义。女性检出率高于男性(64.5%vs.56.0%);45~59岁者检出率高于其他年龄段(71.3%vs.53.4%、53.2%、60.2%);非在职者检出率高于在职者(64.2%vs.54.9%);内科就诊者检出率高于外科及其他科室就诊者(64.5%vs.47.4%),均P0.05。PHQ-15得分≥15分者合并抑郁(93.1%vs.0、2.5%、46.7%)、焦虑(34.5%vs.0.4%、2.5%、12.0%)、抑郁合并焦虑症状群检出率(31.0%vs.0、0.4%、4.3%)均高于其他分值者(均P0.001)。结论:患者健康问卷躯体症状群量表中文版可用于筛查躯体症状为表现的精神问题和躯体症状严重程度的评估,具有较好的信效度。
[Abstract]:Objective: to explore the screening value of Chinese version of physical symptom Group scale (PHQ-15) in outpatients of general hospital. Methods: the Chinese version of PHQ-15, the General anxiety scale (GAD-7) and the depressive symptom Group scale (PHQ-9) were completed under the prescribed instructions, and the trained psychiatry professionals were evaluated with Hamilton anxiety scale (HAMA) and Hamilton depression scale (HAMD). Among them, 44 patients were randomly selected to receive PHQ-15 re-test within 7 to 14 days after the completion of the initial assessment. Using HAMA,HAMD,GAD-7,PHQ-9 as the standard, the correlation analysis was carried out with PHQ-15. The detection rate of somatic symptom group was calculated and its demographic characteristics were analyzed. The relationship between different PHQ-15 scores and anxiety and depression symptoms was analyzed. Results: the internal consistency reliability coefficient of PHQ-15 was 0.73, and the test-retest reliability coefficient of 0.75.PHQ-15 was positively correlated with HAMA,HAMD,GAD-7,PHQ-9 score (r 鈮，

本文编号：2518422